Try our Advanced Search for more refined results

Pfizer Hasn't Proved Rare-Disease Drug Works, FDA Staff Says

By Jeff Overley (May 22, 2012, 1:40 PM EDT) -- Staff at the U.S. Food and Drug Administration on Tuesday said Pfizer Inc. has failed to prove the effectiveness of nerve disorder treatment Vyndaqel and recommended against approving the drug, potentially hampering the firm's foray into the rare-disease market....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!